2010 versus the 2000 consensus criteria in patients with normalised insulin‐like growth factor 1 after transsphenoidal surgery has high predictive values for long‐term recurrence‐free survival in acromegaly - Shen - 2021

Insulin-like growth factor-1 level is a poor diagnostic indicator of growth hormone deficiency

Personalized Medical Treatment of Patients With Acromegaly: A Review - ScienceDirect

Insulin-Like Growth Factor 1 Predicts Post-Load Hypoglycemia following Bariatric Surgery: A Prospective Cohort Study

Long-term outcomes of transsphenoidal surgery for management of growth hormone–secreting adenomas: single-center results in: Journal of Neurosurgery Volume 133 Issue 5 (2019) Journals

Acromegaly SpringerLink

Acromegaly - ScienceDirect

PDF) Treatment of Acromegaly by Rosiglitazone via up-regulating 15-PGDH in Both Pituitary Adenoma and Liver

Acromegaly - ScienceDirect

pasireotide

JCM, Free Full-Text

Diagnosis and Treatment of Acromegaly: An Update - Mayo Clinic Proceedings

Frontiers Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly